News Releases

MARLBOROUGH, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be virtually participating in the Canaccord 41st Annual Growth Conference. Brian McKelligon, CEO is scheduled to present on Wednesday,...

MARLBOROUGH, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will release financial results for the second quarter of 2021 after the market close on Tuesday, August 10, 2021....

Results from the study provide evidence of standardization of an automated spatial biology workflow, based on the company’s Phenoptics™ multiplex immunofluorescence (mIF) platform, for clinical and translational research MARLBOROUGH, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc.,...

Company plans to work with multiple microscope partners to broaden access to the CODEX® solution for single-cell, multiplexed imaging MARLBOROUGH, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced partnerships with premier...

MARLBOROUGH, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company ® , today announced the appointment of diagnostics industry leader Scott Mendel to its board of directors. “I am delighted to join the board of directors of Akoya, a company...

CODEX’s single-cell, multiplex imaging capabilities to be included in Chan Zuckerberg Initiative grantee toolkit to help fuel the next wave of biological discoveries MARLBOROUGH, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today...

Investigators at Johns Hopkins University (JHU) used AstroPath to identify and validate biomarkers for accurate prediction of long-term response to immune checkpoint inhibitors in advanced melanoma AstroPath combines JHU’s famed 3D sky mapping algorithms for managing astronomical-scale datasets...

MARLBOROUGH, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, is set to join the broad-market Russell 3000 ®  Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on...

Partnership aims to leverage spatial biology data, generated on Akoya’s Phenoptics™ platform, to inform and guide drug development programs MARLBOROUGH, Mass., June 04, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today announced a collaboration...

Company launches Advanced Biopharma Solutions (ABS), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials MARLBOROUGH, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today...